| Year |
Citation |
Score |
| 2021 |
Yu G, Shen P, Lee YC, Pan J, Song JH, Pan T, Lin SC, Liang X, Wang G, Panaretakis T, Logothetis CJ, Gallick GE, Yu-Lee LY, Lin SH. Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4. Iscience. 24: 102388. PMID 33981975 DOI: 10.1016/j.isci.2021.102388 |
0.342 |
|
| 2020 |
Koinis F, Corn P, Parikh N, Song J, Vardaki I, Mourkioti I, Lin SH, Logothetis C, Panaretakis T, Gallick G. Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer. Cancers. 12. PMID 31963871 DOI: 10.3390/Cancers12010244 |
0.404 |
|
| 2018 |
Yu G, Cheng CJ, Lin SC, Lee YC, Frigo DE, Yu-Lee LY, Gallick GE, Titus MA, Nutt LK, Lin SH. Organelle-derived acetyl-CoA promotes prostate cancer cell survival, migration, and metastasis via activation of calmodulin kinase II. Cancer Research. PMID 29535221 DOI: 10.1158/0008-5472.Can-17-2392 |
0.413 |
|
| 2018 |
Yu-Lee LY, Yu G, Lee YC, Lin SC, Pan J, Pan T, Yu KJ, Liu B, Creighton CJ, Rodriguez-Canales J, Villalobos PA, Wistuba II, de Nadal E, Posas F, Gallick GE, et al. Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGFβRIII-p38MAPK-pS249/T252RB pathway. Cancer Research. PMID 29514796 DOI: 10.1158/0008-5472.Can-17-1051 |
0.42 |
|
| 2017 |
Yu KJ, Li JK, Lee YC, Yu G, Lin SC, Pan T, Satcher RL, Titus MA, Yu-Lee LY, Weng WH, Gallick GE, Lin SH. Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in bone. Oncotarget. 8: 74987-75006. PMID 29088840 DOI: 10.18632/oncotarget.20489 |
0.377 |
|
| 2017 |
Lin SC, Lee YC, Yu G, Cheng CJ, Zhou X, Chu K, Murshed M, Le NT, Baseler L, Abe JI, Fujiwara K, deCrombrugghe B, Logothetis CJ, Gallick GE, Yu-Lee LY, et al. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. Developmental Cell. 41: 467-480.e3. PMID 28586644 DOI: 10.1016/J.Devcel.2017.05.005 |
0.322 |
|
| 2017 |
Li L, Karanika S, Yang G, Wang J, Park S, Broom BM, Manyam GC, Wu W, Luo Y, Basourakos S, Song JH, Gallick GE, Karantanos T, Korentzelos D, Azad AK, et al. Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer. Science Signaling. 10. PMID 28536297 DOI: 10.1126/Scisignal.Aam7479 |
0.305 |
|
| 2015 |
Lee YC, Lin SC, Yu G, Cheng CJ, Liu B, Liu HC, Hawke DH, Parikh NU, Varkaris A, Corn P, Logothetis C, Satcher RL, Yu-Lee LY, Gallick GE, Lin SH. Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Research. PMID 26530902 DOI: 10.1158/0008-5472.CAN-15-1215 |
0.42 |
|
| 2015 |
Reddy SM, Kopetz S, Morris J, Parikh N, Qiao W, Overman MJ, Fogelman D, Shureiqi I, Jacobs C, Malik Z, Jimenez CA, Wolff RA, Abbruzzese JL, Gallick G, Eng C. Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer. Investigational New Drugs. 33: 977-84. PMID 26062928 DOI: 10.1007/S10637-015-0257-Z |
0.385 |
|
| 2015 |
Chatterji T, Varkaris AS, Parikh NU, Song JH, Cheng CJ, Schweppe RE, Alexander S, Davis JW, Troncoso P, Friedl P, Kuang J, Lin SH, Gallick GE. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells. Oncotarget. 6: 10175-94. PMID 25868388 DOI: 10.18632/Oncotarget.3391 |
0.436 |
|
| 2015 |
Lee YC, Gajdosik MS, Josic D, Clifton JG, Logothetis C, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment. Molecular & Cellular Proteomics : McP. 14: 471-83. PMID 25527621 DOI: 10.1074/Mcp.M114.039909 |
0.427 |
|
| 2015 |
Yu G, Lee YC, Cheng CJ, Wu CF, Song JH, Gallick GE, Yu-Lee LY, Kuang J, Lin SH. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival. Molecular Cancer Research : McR. 13: 348-57. PMID 25189355 DOI: 10.1158/1541-7786.MCR-14-0384-T |
0.34 |
|
| 2014 |
Kopetz S, Morris VK, Parikh N, Overman MJ, Jiang ZQ, Maru D, Elvin P, Gallick G. Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer Bmc Cancer. 14. PMID 25208577 DOI: 10.1186/1471-2407-14-660 |
0.421 |
|
| 2014 |
Satcher RL, Pan T, Cheng CJ, Lee YC, Lin SC, Yu G, Li X, Hoang AG, Tamboli P, Jonasch E, Gallick GE, Lin SH. Cadherin-11 in renal cell carcinoma bone metastasis. Plos One. 9: e89880. PMID 24587095 DOI: 10.1371/journal.pone.0089880 |
0.396 |
|
| 2014 |
Gaur S, Gallick G. Abstract 4356: Tumor suppressive miRNA-145 inhibits IGF-1 and cell viability in prostate cancer cells Cancer Research. 74: 4356-4356. DOI: 10.1158/1538-7445.Am2014-4356 |
0.398 |
|
| 2013 |
Bartley AN, Parikh N, Hsu CH, Roe DJ, Buckmeier JA, Corley L, Phipps RA, Gallick G, Lance P, Thompson PA, Hamilton SR. Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia. Cancer Prevention Research (Philadelphia, Pa.). 6: 1162-70. PMID 24008128 DOI: 10.1158/1940-6207.Capr-13-0113 |
0.411 |
|
| 2013 |
Lee YC, Bilen MA, Yu G, Lin SC, Huang CF, Ortiz A, Cho H, Song JH, Satcher RL, Kuang J, Gallick GE, Yu-Lee LY, Huang W, Lin SH. Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis. Molecular Cancer Research : McR. 11: 1401-11. PMID 23913163 DOI: 10.1158/1541-7786.MCR-13-0108 |
0.393 |
|
| 2013 |
Varkaris A, Gaur S, Parikh NU, Song JH, Dayyani F, Jin JK, Logothetis CJ, Gallick GE. Ligand-independent activation of MET through IGF-1/IGF-1R signaling. International Journal of Cancer. Journal International Du Cancer. 133: 1536-46. PMID 23526299 DOI: 10.1002/ijc.28169 |
0.335 |
|
| 2013 |
Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, ... ... Gallick GE, et al. Src activation by β-adrenoreceptors is a key switch for tumour metastasis. Nature Communications. 4: 1403. PMID 23360994 DOI: 10.1038/Ncomms2413 |
0.306 |
|
| 2013 |
Lee YC, Jin JK, Cheng CJ, Huang CF, Song JH, Huang M, Brown WS, Zhang S, Yu-Lee LY, Yeh ET, McIntyre BW, Logothetis CJ, Gallick GE, Lin SH. Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis. Molecular Cancer Research : McR. 11: 405-17. PMID 23339185 DOI: 10.1158/1541-7786.Mcr-12-0551 |
0.376 |
|
| 2012 |
Dayyani F, Parikh NU, Varkaris AS, Song JH, Moorthy S, Chatterji T, Maity SN, Wolfe AR, Carboni JM, Gottardis MM, Logothetis CJ, Gallick GE. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways. Plos One. 7: e51189. PMID 23300537 DOI: 10.1371/Journal.Pone.0051189 |
0.32 |
|
| 2012 |
Kim MP, Truty MJ, Choi W, Kang Y, Chopin-Lally X, Gallick GE, Wang H, McConkey DJ, Hwang R, Logsdon C, Abbruzzesse J, Fleming JB. Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy. Annals of Surgical Oncology. 19: S395-403. PMID 21701930 DOI: 10.1245/S10434-011-1839-4 |
0.33 |
|
| 2011 |
Matsuo K, Nishimura M, Bottsford-Miller JN, Huang J, Komurov K, Armaiz-Pena GN, Shahzad MM, Stone RL, Roh JW, Sanguino AM, Lu C, Im DD, Rosenshien NB, Sakakibara A, Nagano T, ... ... Gallick GE, et al. Targeting SRC in mucinous ovarian carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5367-78. PMID 21737505 DOI: 10.1158/1078-0432.Ccr-10-3176 |
0.349 |
|
| 2011 |
Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. Plos One. 6: e20636. PMID 21695188 DOI: 10.1371/Journal.Pone.0020636 |
0.425 |
|
| 2011 |
Kim HS, Han HD, Armaiz-Pena GN, Stone RL, Nam EJ, Lee JW, Shahzad MM, Nick AM, Lee SJ, Roh JW, Nishimura M, Mangala LS, Bottsford-Miller J, Gallick GE, Lopez-Berestein G, et al. Functional roles of Src and Fgr in ovarian carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1713-21. PMID 21300758 DOI: 10.1158/1078-0432.Ccr-10-2081 |
0.444 |
|
| 2011 |
Liu JL, Mao Z, Gallick GE, Yung WK. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor. Neuro-Oncology. 13: 184-94. PMID 21123367 DOI: 10.1093/neuonc/noq163 |
0.363 |
|
| 2011 |
Mao M, Tsao L, Dayyani F, Nanda VGY, Mills G, Bollag G, Davies M, Gallick G, Kopetz S. Abstract LB-228: Resistance to BRAF inhibition in BRAF V600E colorectal cancer is associated with PI3K/AKT activation and hypermethylation Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-228 |
0.486 |
|
| 2010 |
Park SI, Kim SJ, McCauley LK, Gallick GE. Pre-clinical mouse models of human prostate cancer and their utility in drug discovery. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit 14.15. PMID 21483646 DOI: 10.1002/0471141755.Ph1415S51 |
0.566 |
|
| 2010 |
Connelly SF, Isley BA, Baker CH, Gallick GE, Summy JM. Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-Src in detached pancreatic cells. Molecular Carcinogenesis. 49: 1007-21. PMID 20945416 DOI: 10.1002/mc.20684 |
0.458 |
|
| 2009 |
Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nature Protocols. 4: 1670-80. PMID 19876027 DOI: 10.1038/nprot.2009.171 |
0.405 |
|
| 2009 |
Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey DJ, Choi W. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Research. 69: 5820-8. PMID 19584296 DOI: 10.1158/0008-5472.Can-08-2819 |
0.353 |
|
| 2009 |
Kopetz S, Lesslie DP, Dallas NA, Park SI, Johnson M, Parikh NU, Kim MP, Abbruzzese JL, Ellis LM, Chandra J, Gallick GE. Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress. Cancer Research. 69: 3842-9. PMID 19383922 DOI: 10.1158/0008-5472.CAN-08-2246 |
0.633 |
|
| 2009 |
Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, Azmi AS, Ali S, Abbruzzese JL, Gallick GE, Sarkar FH. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Research. 69: 2400-7. PMID 19276344 DOI: 10.1158/0008-5472.Can-08-4312 |
0.402 |
|
| 2009 |
Sen B, Saigal B, Parikh N, Gallick G, Johnson FM. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding. Cancer Research. 69: 1958-65. PMID 19223541 DOI: 10.1158/0008-5472.Can-08-2944 |
0.465 |
|
| 2009 |
Kim MP, Park SI, Kopetz S, Gallick GE. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis. Cell and Tissue Research. 335: 249-59. PMID 18815812 DOI: 10.1007/S00441-008-0682-9 |
0.643 |
|
| 2009 |
Araujo J, Mathew P, Armstrong AJ, Braud EL, Posadas E, Lonberg M, Gallick G, Trudel GC, Paliwal P, Logothetis CJ. 7028 Dasatinib and docetaxel combination treatment for patients with metastatic castration-resistant prostate cancer (CRPC): analysis of Study CA180–086 Ejc Supplements. 7: 415. DOI: 10.1016/S1359-6349(09)71406-5 |
0.312 |
|
| 2008 |
Guan H, Zhou Z, Gallick GE, Jia SF, Morales J, Sood AK, Corey SJ, Kleinerman ES. Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma. Molecular Cancer Therapeutics. 7: 1807-16. PMID 18644993 DOI: 10.1158/1535-7163.Mct-08-0058 |
0.488 |
|
| 2008 |
Pan S, Wang R, Zhou X, Corvera J, Kloc M, Sifers R, Gallick GE, Lin SH, Kuang J. Extracellular Alix regulates integrin-mediated cell adhesions and extracellular matrix assembly. The Embo Journal. 27: 2077-90. PMID 18636094 DOI: 10.1038/emboj.2008.134 |
0.316 |
|
| 2008 |
Park SI, Zhang J, Phillips KA, Araujo JC, Najjar AM, Volgin AY, Gelovani JG, Kim SJ, Wang Z, Gallick GE. Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model. Cancer Research. 68: 3323-33. PMID 18451159 DOI: 10.1158/0008-5472.Can-07-2997 |
0.679 |
|
| 2008 |
Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, El-Naggar AK. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer. 112: 2088-100. PMID 18327819 DOI: 10.1002/Cncr.23410 |
0.513 |
|
| 2007 |
Kopetz S, Shah AN, Gallick GE. Src continues aging: current and future clinical directions. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7232-6. PMID 18094400 DOI: 10.1158/1078-0432.CCR-07-1902 |
0.314 |
|
| 2007 |
Johnson FM, Gallick GE. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy. Anti-Cancer Agents in Medicinal Chemistry. 7: 651-9. PMID 18045060 DOI: 10.2174/187152007784111278 |
0.373 |
|
| 2007 |
Liu JL, Mao Z, LaFortune TA, Alonso MM, Gallick GE, Fueyo J, Yung WK. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade. Cancer Research. 67: 11054-63. PMID 18006852 DOI: 10.1158/0008-5472.CAN-07-1263 |
0.438 |
|
| 2007 |
Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, Gallick GE. Development and characterization of gemcitabine-resistant pancreatic tumor cells. Annals of Surgical Oncology. 14: 3629-37. PMID 17909916 DOI: 10.1245/S10434-007-9583-5 |
0.614 |
|
| 2007 |
Zhang J, Park SI, Artime MC, Summy JM, Shah AN, Bomser JA, Dorfleutner A, Flynn DC, Gallick GE. AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. The Journal of Clinical Investigation. 117: 2962-73. PMID 17885682 DOI: 10.1172/Jci30710 |
0.633 |
|
| 2007 |
Park SI, Shah AN, Zhang J, Gallick GE. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors. Expert Opinion On Therapeutic Targets. 11: 1207-17. PMID 17845146 DOI: 10.1517/14728222.11.9.1207 |
0.663 |
|
| 2007 |
Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism Journal of Biological Chemistry. 282: 29919-29926. PMID 17716980 DOI: 10.1074/Jbc.M611539200 |
0.363 |
|
| 2007 |
Herynk MH, Zhang J, Parikh NU, Gallick GE. Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells. Journal of Experimental Therapeutics & Oncology. 6: 205-17. PMID 17552361 |
0.79 |
|
| 2007 |
Dorfleutner A, Stehlik C, Zhang J, Gallick GE, Flynn DC. AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells. Journal of Cellular Physiology. 213: 740-9. PMID 17520695 DOI: 10.1002/jcp.21143 |
0.335 |
|
| 2007 |
Shah AN, Gallick GE. Src, chemoresistance and epithelial to mesenchymal transition: are they related? Anti-Cancer Drugs. 18: 371-5. PMID 17351389 DOI: 10.1097/CAD.0b013e32801265d7 |
0.446 |
|
| 2007 |
El-Naggar AK, Lippman SM, Johnson FM, Mandal M, Myers JN, Williams MD, Rosenthal DI, Weber RS, Gallick G. Correlation of Src activation with epithelial-mesenchymal transformation and aggressive features of head and neck squamous carcinoma Journal of Clinical Oncology. 25: 6026-6026. DOI: 10.1200/Jco.2007.25.18_Suppl.6026 |
0.391 |
|
| 2007 |
Shah AN, Gallick G. P228: Gemcitabine resistance of pancreatic tumor cells in culture is associated with properties of epithelial to mesenchymal transition Journal of Surgical Research. 137: 322-323. DOI: 10.1016/J.Jss.2006.12.412 |
0.427 |
|
| 2006 |
Minard ME, Ellis LM, Gallick GE. Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clinical & Experimental Metastasis. 23: 301-13. PMID 17086355 DOI: 10.1007/S10585-006-9040-Z |
0.759 |
|
| 2006 |
Landen CN, Lu C, Han LY, Coffman KT, Bruckheimer E, Halder J, Mangala LS, Merritt WM, Lin YG, Gao C, Schmandt R, Kamat AA, Li Y, Thaker P, Gershenson DM, ... ... Gallick GE, et al. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. Journal of the National Cancer Institute. 98: 1558-70. PMID 17077358 DOI: 10.1093/Jnci/Djj414 |
0.34 |
|
| 2006 |
Han LY, Landen CN, Trevino JG, Halder J, Lin YG, Kamat AA, Kim TJ, Merritt WM, Coleman RL, Gershenson DM, Shakespeare WC, Wang Y, Sundaramoorth R, Metcalf CA, Dalgarno DC, ... ... Gallick GE, et al. Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma. Cancer Research. 66: 8633-9. PMID 16951177 DOI: 10.1158/0008-5472.Can-06-1410 |
0.427 |
|
| 2006 |
Yang L, Avila H, Wang H, Trevino J, Gallick GE, Kitadai Y, Sasaki T, Boyd DD. Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression. Cancer Research. 66: 7957-67. PMID 16912170 DOI: 10.1158/0008-5472.CAN-05-3208 |
0.494 |
|
| 2006 |
Bauer TW, Somcio RJ, Fan F, Liu W, Johnson M, Lesslie DP, Evans DB, Gallick GE, Ellis LM. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. Molecular Cancer Therapeutics. 5: 1676-82. PMID 16891453 DOI: 10.1158/1535-7163.MCT-05-0175 |
0.445 |
|
| 2006 |
Baker CH, Trevino JG, Summy JM, Zhang F, Caron A, Nesbit M, Gallick GE, Fidler IJ. Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice. International Journal of Oncology. 29: 125-38. PMID 16773192 DOI: 10.3892/Ijo.29.1.125 |
0.47 |
|
| 2006 |
Trevino JG, Summy JM, Lesslie DP, Parikh NU, Hong DS, Lee FY, Donato NJ, Abbruzzese JL, Baker CH, Gallick GE. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. The American Journal of Pathology. 168: 962-72. PMID 16507911 DOI: 10.2353/Ajpath.2006.050570 |
0.519 |
|
| 2006 |
Lesslie D, Parikh N, Shah A, Summy J, Trevino J, Hong D, Donato N, Lee F, Gallick G. Dasatinib (BMS-354825), a dual SRC/ABL tyrosine kinase inhibitor, inhibits tumor formation and prevents malignant ascites in a murine model of peritoneal carcinomatosis Journal of the American College of Surgeons. 203: S87-S88. DOI: 10.1016/J.Jamcollsurg.2006.05.229 |
0.424 |
|
| 2005 |
Summy JM, Trevino JG, Lesslie DP, Baker CH, Shakespeare WC, Wang Y, Sundaramoorthi R, Metcalf CA, Keats JA, Sawyer TK, Gallick GE. AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Molecular Cancer Therapeutics. 4: 1900-11. PMID 16373705 DOI: 10.1158/1535-7163.MCT-05-0171 |
0.513 |
|
| 2005 |
Summy JM, Trevino JG, Baker CH, Gallick GE. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK. Pancreas. 31: 263-74. PMID 16163059 DOI: 10.2958/suizo.21.381 |
0.481 |
|
| 2005 |
Trevino JG, Summy JM, Gray MJ, Nilsson MB, Lesslie DP, Baker CH, Gallick GE. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis. Cancer Research. 65: 7214-22. PMID 16103072 DOI: 10.1158/0008-5472.Can-04-3858 |
0.402 |
|
| 2005 |
Inoue S, Branch CD, Gallick GE, Chada S, Ramesh R. Inhibition of Src kinase activity by Ad-mda7 suppresses vascular endothelial growth factor expression in prostate carcinoma cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 707-15. PMID 16054437 DOI: 10.1016/j.ymthe.2005.05.015 |
0.362 |
|
| 2005 |
Gray MJ, Wey JS, Belcheva A, McCarty MF, Trevino JG, Evans DB, Ellis LM, Gallick GE. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Cancer Research. 65: 3664-70. PMID 15867361 DOI: 10.1158/0008-5472.Can-04-2229 |
0.475 |
|
| 2005 |
Bauer TW, Fan F, Liu W, Johnson M, Parikh NU, Parry GC, Callahan J, Mazar AP, Gallick GE, Ellis LM, Cance WG, Slingluff CL, Smythe WR, Townsend CM. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor Annals of Surgery. 241: 748-758. PMID 15849510 DOI: 10.1097/01.Sla.0000160699.59061.92 |
0.457 |
|
| 2005 |
Minard ME, Herynk MH, Collard JG, Gallick GE. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene. 24: 2568-73. PMID 15735692 DOI: 10.1038/Sj.Onc.1208503 |
0.696 |
|
| 2004 |
Minard ME, Kim LS, Price JE, Gallick GE. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Research and Treatment. 84: 21-32. PMID 14999151 DOI: 10.1023/B:Brea.0000018421.31632.E6 |
0.752 |
|
| 2004 |
Boyd DD, Wang H, Avila H, Parikh NU, Kessler H, Magdolen V, Gallick GE. Combination of an SRC kinase inhibitor with a novel pharmacological antagonist of the urokinase receptor diminishes in vitro colon cancer invasiveness. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 1545-55. PMID 14977859 DOI: 10.1158/1078-0432.Ccr-1565-02 |
0.325 |
|
| 2003 |
Kim SJ, Johnson M, Koterba K, Herynk MH, Uehara H, Gallick GE. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 5161-70. PMID 14613995 |
0.776 |
|
| 2003 |
Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metastasis Reviews. 22: 337-58. PMID 12884910 DOI: 10.1023/A:1023772912750 |
0.428 |
|
| 2003 |
Herynk MH, Tsan R, Radinsky R, Gallick GE. Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin. Clinical & Experimental Metastasis. 20: 291-300. PMID 12856716 |
0.798 |
|
| 2003 |
Herynk MH, Stoeltzing O, Reinmuth N, Parikh NU, Abounader R, Laterra J, Radinsky R, Ellis LM, Gallick GE. Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Research. 63: 2990-6. PMID 12782608 |
0.785 |
|
| 2003 |
Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF, Ellis LM. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Research. 63: 2079-87. PMID 12727823 |
0.382 |
|
| 2003 |
Donato NJ, Wu JY, Stapley J, Gallick G, Lin H, Arlinghaus R, Talpaz M. BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood. 101: 690-8. PMID 12509383 DOI: 10.1182/Blood.V101.2.690 |
0.415 |
|
| 2002 |
Windham TC, Parikh NU, Siwak DR, Summy JM, McConkey DJ, Kraker AJ, Gallick GE. Src activation regulates anoikis in human colon tumor cell lines. Oncogene. 21: 7797-807. PMID 12420216 DOI: 10.1038/Sj.Onc.1205989 |
0.507 |
|
| 2002 |
Reinmuth N, Fan F, Liu W, Parikh AA, Stoeltzing O, Jung YD, Bucana CD, Radinsky R, Gallick GE, Ellis LM. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 82: 1377-89. PMID 12379772 |
0.443 |
|
| 2002 |
Davies MA, Kim SJ, Parikh NU, Dong Z, Bucana CD, Gallick GE. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 1904-14. PMID 12060635 |
0.366 |
|
| 2002 |
Aligayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, Gallick GE. Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer. 94: 344-51. PMID 11900220 DOI: 10.1002/cncr.10221 |
0.306 |
|
| 1988 |
Tsuchiya H, Epstein J, Selvanayagam P, Dedman JR, Gallick G, Alexanian R, Barlogie B. Correlated Flow Cytometric Analysis of H-ras p21 and Nuclear DNA in Multiple Myeloma Blood. 72: 796-800. DOI: 10.1182/Blood.V72.2.796.796 |
0.3 |
|
| Show low-probability matches. |